Lupin unveils fixed-dose triple drug combination DIFIZMA DPI for inadequately controlled asthma Ruchika Sharma6 Jan 2023 11:38 AM IST"DIFIZMA is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled Asthma,"...
EMA validates marketing authorization application for Trodelvy for Pre-treated HR+/HER2- Metastatic Breast Cancer: Gilead Sciences Ruchika Sharma5 Jan 2023 4:30 PM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Pfizer India announces 12-week paternity leave policy for its workforce Ruchika Sharma5 Jan 2023 3:29 PM ISTThe paternity leave policy offers birthing and non-birthing fathers the flexibility to avail leaves over a period of two years.
Gland Pharma gets UFSDA EIR for Dundigal Facility Ruchika Sharma5 Jan 2023 2:30 PM ISTHyderabad: Gland Pharma has received the Establishment Inspection Report (EIR) from the Office of Product Evaluation and Quality Center for Devices...
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
Johnson and Johnson consumer health unit Kenvue files for IPO Ruchika Sharma5 Jan 2023 12:15 PM ISTKenvue said J&J will continue to own at least 80.1% of the voting power of the company’s shares upon completion of the offering.
Moderna to buy OriCiro Genomics for USD 85 million Ruchika Sharma5 Jan 2023 11:18 AM ISTCambridge: Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement through which Moderna will...
Molbio Diagnostics unveils Herpes Simplex Virus test 'Truenat HSV-1/2' Ruchika Sharma4 Jan 2023 2:59 PM ISTNew Delhi: Molbio Diagnostics has launched the Truenat HSV 1/2 for testing the Herpes Simplex Virus. The test is approved by CDSCO and can...
Bristol Myers Squibb concludes sale of New York manufacturing facility Ruchika Sharma4 Jan 2023 2:30 PM ISTNew York: Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, New York to LOTTE...
Viatris closes acquisitions of Famy Life Sciences, Oyster Point Pharma to establish eye care division Ruchika Sharma4 Jan 2023 1:15 PM ISTThe aggregate acquisition price for the Famy Life Sciences business is expected to be approximately $280 million.
Aurinia Pharma enter into a settlement agreement with Sun Pharma Ruchika Sharma4 Jan 2023 12:15 PM ISTCorrigendum: The drug mentioned in the article was earlier misidentified as a dry eye disease drug. It is in fact a Lupus Nephritis Drug. Corrections...
Aurobindo Pharma arm gets USFDA nod for Azacitidine for Injection to treat myelodysplastic syndrome Ruchika Sharma4 Jan 2023 11:07 AM ISTThe product is indicated for the treatment of adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes.
